Metabolic effects of aripiprazole and pimozide in children with tourette syndrome

Pediatric Neurology

Volumn 47, Issue 6, 2012, Pages 419-422

  Rizzo, Renata ^a   Eddy, Clare M ^b   Calí, Paola ^a   Gulisano, Mariangela ^a   Cavanna, Andrea E ^b,c  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; GLUCOSE; HALOPERIDOL; PERICIAZINE; PIMOZIDE; RISPERIDONE; SULPIRIDE;

ARTICLE; BODY MASS; CHILD; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG SAFETY; ENURESIS; FEMALE; GILLES DE LA TOURETTE SYNDROME; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLISM; NAUSEA; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CHOLESTEROL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PIMOZIDE; PIPERAZINES; QUINOLONES; TOURETTE SYNDROME; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84868598852     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2012.08.015     Document Type: Article

References (16)

1. A.E. Cavanna, S. Servo, F. Monaco, and M.M. Robertson The behavioral spectrum of Gilles de la Tourette syndrome J Neuropsychiatry Clin Neurosci 21 2009 13 23
2. C.M. Eddy, R. Rizzo, and M. Gulisano Quality of life in young people with Tourette syndrome: A controlled study J Neurol 258 2011 291 301
3. R.S. Degrauw, J.Z. Li, and D.L. Gilbert Body mass index changes and chronic neuroleptic drug treatment for Tourette syndrome Pediatr Neurol 41 2009 183 186
4. R. Bruggeman, C. van der Linden, J.K. Buitelaar, G.S. Gericke, S.M. Hawkridge, and J.A. Temlett Risperidone versus pimozide in Tourette's disorder: A comparative double-blind parallel-group study J Clin Psychiatry 62 2001 50 56
5. D.L. Gilbert, J.R. Batterson, G. Sethuraman, and F.R. Sallee Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial J Am Acad Child Adolesc Psychiatry 43 2004 206 214
6. C.M. Eddy, H.E. Rickards, and A.E. Cavanna Treatment strategies for tics in Tourette syndrome Ther Adv Neurol Disord 4 2011 25 45
7. G.J. Lyon, S. Samar, and R. Jummani Aripiprazole in children and adolescents with Tourette's disorder: An open-label safety and tolerability study J Child Adolesc Psychopharmacol 19 2009 623 633
8. T.K. Murphy, P.J. Mutch, and J.M. Reid Open label aripiprazole in the treatment of youth with tic disorders J Child Adolesc Psychopharmacol 19 2009 441 447
9. T.K. Murphy, M.A. Bengtson, and O. Soto Case series on the use of aripiprazole for Tourette syndrome Int J Neuropsychopharmacol 8 2005 489 490
10. C. Budman, B.J. Coffey, and R. Shechter Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts J Child Adolesc Psychopharmacol 18 2008 509 515
11. M. Gulisano, P.V. Calì, A.E. Cavanna, C. Eddy, H. Rickards, and R. Rizzo Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome Neurol Sci 32 2011 1213 1217
12. W.S. Seo, H.M. Sung, H.S. Sea, and D.S. Bai Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder J Child Adolesc Psychopharmacol 18 2008 197 205
13. C. Wenzel, A. Kleimann, S. Bokemeyer, and K.R. Müller-Vahl Aripiprazole for the treatment of Tourette syndrome: A case series of 100 patients J Clin Psychopharmacol 32 2012 548 550
14. B.-C. Ho, N.A. Andreason, S. Ziebell, R. Pierson, and V. Magnotta Long-term antipsychotic treatment and brain volumes Arch Gen Psychiatry 68 2011 128 137
15. H.C. Margolese, G. Chouinard, T.T. Kolivakis, L. Beauclair, R. Miller, and L. Annable Tardive dyskinesia in the era of typical and atypical antipsychotics part 2: Incidence and management strategies in patients with schizophrenia Can J Psychiatry 50 2005 703 714
16. K.R. Müller-Vahl, and D. Krueger Does Tourette syndrome prevent tardive dyskinesia? Mov Disord 26 2011 2442 2443